Form EFFECT bioAffinity Technologies
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | September 4, 2026 5:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AmericanAg® Announces Retirement of Senior VP Pat Larsen
- 2026 China Da Hai Dao International Rally kicks off
- Best Crypto Presale: Bitcoin Falls Below $79K as DigiTap Raises $11.37M With Round 4 Already 84% Sold
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
